Atlas Trials

Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants

Clinical trial NCT06037148 · COMPLETED

Trial details

NCT number
NCT06037148
Sponsor
Desentum Oy
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Birch Pollen Allergy
Start date
2023-09-07
Primary completion
2024-03-06
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.